×

β-D-2′-deoxy-2′-α-fluoro-2′β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

  • US 10,005,811 B2
  • Filed: 10/12/2017
  • Issued: 06/26/2018
  • Est. Priority Date: 03/06/2015
  • Status: Active Grant
First Claim
Patent Images

1. A compound of Formula:

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×